Citation: Ti. Chang et Mr. Loeken, Genotoxicity and diabetic embryopathy: Impaired expression of developmental control genes as a cause of defective morphogenesis, SEM REP END, 17(2), 1999, pp. 153-165
Authors:
Schatz, F
Krikun, G
Runic, R
Wang, EY
Hausknecht, V
Lockwood, CJ
Citation: F. Schatz et al., Implications of decidualization-associated protease expression in implantation and menstruation, SEM REP END, 17(1), 1999, pp. 3-12
Citation: Lc. Giudice et Jc. Irwin, Roles of the insulinlike growth factor family in nonpregnant human endometrium and at the Decidual: Trophoblast interface, SEM REP END, 17(1), 1999, pp. 13-21
Citation: A. Gravanis et al., Paracrinology of endometrial neuropeptides: Corticotropin-releasing hormone and opioids, SEM REP END, 17(1), 1999, pp. 29-38
Citation: S. Guller et L. Lachapelle, The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces, SEM REP END, 17(1), 1999, pp. 39-44
Citation: F. Arcuri et al., Expression of 11 beta-hydroxysteroid dehydrogenase in early pregnancy: Implications in human trophoblast-endometrial interactions, SEM REP END, 17(1), 1999, pp. 53-61
Citation: Li. Gold et Tv. Parekh, Loss of growth regulation by transforming growth factor-beta (TGF-beta) inhuman cancers: Studies on endometrial carcinoma, SEM REP END, 17(1), 1999, pp. 73-92
Citation: Kl. Sharpe-timms et Sr. Glasser, Models for the study of uterine receptivity for blastocyst implantation, SEM REP END, 17(1), 1999, pp. 107-115
Citation: L. Nathan et G. Chaudhuri, Antioxidant and prooxidant actions of estrogens: Potential physiological and clinical implications, SEM REP END, 16(4), 1998, pp. 309-314